Industry: Pharma & Healthcare
Published Date: 2025-04-18
Pages: 158 Pages
Report ld: 4712750
Request Sample
Customized Report
Custom DNA Oligos Market Size(US$)

CAGR 2025-2031
7.8%
Market Size,2031
USD 353
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Custom DNA Oligos market is projected to grow from US$ 225 million in 2025 to US$ 353 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Custom DNA oligos are short, single-stranded DNA sequences synthesized according to specific customer requirements. They are widely used in molecular biology applications such as PCR, qPCR, sequencing, cloning, gene editing, and hybridization assays. These oligos can be customized with various modifications, including fluorescent labels, phosphorothioate bonds, or 5'/3' end modifications to suit diverse research and diagnostic purposes.
The US & Canada market for Custom DNA Oligos is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Custom DNA Oligos is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Custom DNA Oligos is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key manufacturers of Custom DNA Oligos include Thermo Fisher Scientific, Merck, Azenta Life Sciences, BBI Life Sciences, TriLink BioTechnologies, Aurigene Pharmaceutical Services, Integrated DNA Technologies (IDT), Cusabio, Macrogen, Synbio Technologies, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Custom DNA Oligos production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Custom DNA Oligos by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Custom DNA Oligos, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Custom DNA Oligos, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Custom DNA Oligos, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Custom DNA Oligos sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Custom DNA Oligos market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Custom DNA Oligos sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Merck, Azenta Life Sciences, BBI Life Sciences, TriLink BioTechnologies, Aurigene Pharmaceutical Services, Integrated DNA Technologies (IDT), Cusabio, Macrogen, Synbio Technologies, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Custom DNA Oligos production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Custom DNA Oligos in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Custom DNA Oligos manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom DNA Oligos sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom DNA Oligos Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Common Primer Synthesis
1.2.3 Modified Primer Synthesis
1.3 Market by Application
1.3.1 Global Custom DNA Oligos Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biotech Company
1.3.3 Academic Scientific Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom DNA Oligos Market Perspective (2020-2031)
2.2 Global Custom DNA Oligos Growth Trends by Region
2.2.1 Global Custom DNA Oligos Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Custom DNA Oligos Market Size by Region (2020-2031)
2.3 Custom DNA Oligos Market Dynamics
2.3.1 Custom DNA Oligos Industry Trends
2.3.2 Custom DNA Oligos Market Drivers
2.3.3 Custom DNA Oligos Market Challenges
2.3.4 Custom DNA Oligos Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Custom DNA Oligos by Players
3.1.1 Global Custom DNA Oligos Revenue by Players (2020-2025)
3.1.2 Global Custom DNA Oligos Revenue Market Share by Players (2020-2025)
3.2 Global Custom DNA Oligos Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Custom DNA Oligos, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Custom DNA Oligos Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom DNA Oligos Revenue in 2024
3.5 Global Key Players of Custom DNA Oligos Head office and Area Served
3.6 Global Key Players of Custom DNA Oligos, Product and Application
3.7 Global Key Players of Custom DNA Oligos, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Custom DNA Oligos Historic Market Size by Type (2020-2025)
4.2 Global Custom DNA Oligos Forecasted Market Size by Type (2026-2031)
5 Breakdown Data by Application
5.1 Global Custom DNA Oligos Historic Market Size by Application (2020-2025)
5.2 Global Custom DNA Oligos Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Custom DNA Oligos Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Custom DNA Oligos Market Size by Type (2020-2031)
6.2.2 North America Custom DNA Oligos Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Custom DNA Oligos Market Size by Application (2020-2031)
6.3.2 North America Custom DNA Oligos Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Custom DNA Oligos Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Custom DNA Oligos Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Custom DNA Oligos Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Custom DNA Oligos Market Size by Type (2020-2031)
7.2.2 Europe Custom DNA Oligos Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Custom DNA Oligos Market Size by Application (2020-2031)
7.3.2 Europe Custom DNA Oligos Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Custom DNA Oligos Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Custom DNA Oligos Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Custom DNA Oligos Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Custom DNA Oligos Market Size by Type (2020-2031)
8.2.2 China Custom DNA Oligos Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Custom DNA Oligos Market Size by Application (2020-2031)
8.3.2 China Custom DNA Oligos Market Share by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Custom DNA Oligos Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Custom DNA Oligos Market Size by Type (2020-2031)
9.2.2 Asia Custom DNA Oligos Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Custom DNA Oligos Market Size by Application (2020-2031)
9.3.2 Asia Custom DNA Oligos Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Custom DNA Oligos Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Custom DNA Oligos Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Custom DNA Oligos Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Custom DNA Oligos Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Custom DNA Oligos Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Custom DNA Oligos Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Custom DNA Oligos Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Custom DNA Oligos Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Custom DNA Oligos Introduction
11.1.4 Thermo Fisher Scientific Revenue in Custom DNA Oligos Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Custom DNA Oligos Introduction
11.2.4 Merck Revenue in Custom DNA Oligos Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Details
11.3.2 Azenta Life Sciences Business Overview
11.3.3 Azenta Life Sciences Custom DNA Oligos Introduction
11.3.4 Azenta Life Sciences Revenue in Custom DNA Oligos Business (2020-2025)
11.3.5 Azenta Life Sciences Recent Development
11.4 BBI Life Sciences
11.4.1 BBI Life Sciences Company Details
11.4.2 BBI Life Sciences Business Overview
11.4.3 BBI Life Sciences Custom DNA Oligos Introduction
11.4.4 BBI Life Sciences Revenue in Custom DNA Oligos Business (2020-2025)
11.4.5 BBI Life Sciences Recent Development
11.5 TriLink BioTechnologies
11.5.1 TriLink BioTechnologies Company Details
11.5.2 TriLink BioTechnologies Business Overview
11.5.3 TriLink BioTechnologies Custom DNA Oligos Introduction
11.5.4 TriLink BioTechnologies Revenue in Custom DNA Oligos Business (2020-2025)
11.5.5 TriLink BioTechnologies Recent Development
11.6 Aurigene Pharmaceutical Services
11.6.1 Aurigene Pharmaceutical Services Company Details
11.6.2 Aurigene Pharmaceutical Services Business Overview
11.6.3 Aurigene Pharmaceutical Services Custom DNA Oligos Introduction
11.6.4 Aurigene Pharmaceutical Services Revenue in Custom DNA Oligos Business (2020-2025)
11.6.5 Aurigene Pharmaceutical Services Recent Development
11.7 Integrated DNA Technologies (IDT)
11.7.1 Integrated DNA Technologies (IDT) Company Details
11.7.2 Integrated DNA Technologies (IDT) Business Overview
11.7.3 Integrated DNA Technologies (IDT) Custom DNA Oligos Introduction
11.7.4 Integrated DNA Technologies (IDT) Revenue in Custom DNA Oligos Business (2020-2025)
11.7.5 Integrated DNA Technologies (IDT) Recent Development
11.8 Cusabio
11.8.1 Cusabio Company Details
11.8.2 Cusabio Business Overview
11.8.3 Cusabio Custom DNA Oligos Introduction
11.8.4 Cusabio Revenue in Custom DNA Oligos Business (2020-2025)
11.8.5 Cusabio Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Custom DNA Oligos Introduction
11.9.4 Macrogen Revenue in Custom DNA Oligos Business (2020-2025)
11.9.5 Macrogen Recent Development
11.10 Synbio Technologies
11.10.1 Synbio Technologies Company Details
11.10.2 Synbio Technologies Business Overview
11.10.3 Synbio Technologies Custom DNA Oligos Introduction
11.10.4 Synbio Technologies Revenue in Custom DNA Oligos Business (2020-2025)
11.10.5 Synbio Technologies Recent Development
11.11 Eurogentec
11.11.1 Eurogentec Company Details
11.11.2 Eurogentec Business Overview
11.11.3 Eurogentec Custom DNA Oligos Introduction
11.11.4 Eurogentec Revenue in Custom DNA Oligos Business (2020-2025)
11.11.5 Eurogentec Recent Development
11.12 Genscript
11.12.1 Genscript Company Details
11.12.2 Genscript Business Overview
11.12.3 Genscript Custom DNA Oligos Introduction
11.12.4 Genscript Revenue in Custom DNA Oligos Business (2020-2025)
11.12.5 Genscript Recent Development
11.13 Abace Biotechnology
11.13.1 Abace Biotechnology Company Details
11.13.2 Abace Biotechnology Business Overview
11.13.3 Abace Biotechnology Custom DNA Oligos Introduction
11.13.4 Abace Biotechnology Revenue in Custom DNA Oligos Business (2020-2025)
11.13.5 Abace Biotechnology Recent Development
11.14 Tsingke
11.14.1 Tsingke Company Details
11.14.2 Tsingke Business Overview
11.14.3 Tsingke Custom DNA Oligos Introduction
11.14.4 Tsingke Revenue in Custom DNA Oligos Business (2020-2025)
11.14.5 Tsingke Recent Development
11.15 Guangzhou RiboBio
11.15.1 Guangzhou RiboBio Company Details
11.15.2 Guangzhou RiboBio Business Overview
11.15.3 Guangzhou RiboBio Custom DNA Oligos Introduction
11.15.4 Guangzhou RiboBio Revenue in Custom DNA Oligos Business (2020-2025)
11.15.5 Guangzhou RiboBio Recent Development
11.16 Atantares
11.16.1 Atantares Company Details
11.16.2 Atantares Business Overview
11.16.3 Atantares Custom DNA Oligos Introduction
11.16.4 Atantares Revenue in Custom DNA Oligos Business (2020-2025)
11.16.5 Atantares Recent Development
11.17 Wuhan GeneCreate Biological Engineering
11.17.1 Wuhan GeneCreate Biological Engineering Company Details
11.17.2 Wuhan GeneCreate Biological Engineering Business Overview
11.17.3 Wuhan GeneCreate Biological Engineering Custom DNA Oligos Introduction
11.17.4 Wuhan GeneCreate Biological Engineering Revenue in Custom DNA Oligos Business (2020-2025)
11.17.5 Wuhan GeneCreate Biological Engineering Recent Development
11.18 Beyotime
11.18.1 Beyotime Company Details
11.18.2 Beyotime Business Overview
11.18.3 Beyotime Custom DNA Oligos Introduction
11.18.4 Beyotime Revenue in Custom DNA Oligos Business (2020-2025)
11.18.5 Beyotime Recent Development
11.19 General Biol
11.19.1 General Biol Company Details
11.19.2 General Biol Business Overview
11.19.3 General Biol Custom DNA Oligos Introduction
11.19.4 General Biol Revenue in Custom DNA Oligos Business (2020-2025)
11.19.5 General Biol Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Custom DNA Oligos market is projected to grow from US$ 225 million in 2025 to US$ 378 million by 2032, at a CAGR of 7.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 160
USD 4900.00
(Single User License)
The global Custom DNA Oligos market was valued at US$ 225 million in 2025 and is anticipated to reach US$ 378 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 134
USD 2900.00
(Single User License)
The global Custom DNA Oligos market size was US$ 225 million in 2025 and is forecast to reach a readjusted size of US$ 378 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 103
USD 4250.00
(Single User License)
The global market for Custom DNA Oligos was estimated to be worth US$ 225 million in 2025 and is projected to reach US$ 378 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 131
USD 3950.00
(Single User License)
The global market for Custom DNA Oligos was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 353 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-04-18
Pages: 92
USD 2900.00
(Single User License)
The global market for Custom DNA Oligos was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 353 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-04-18
Pages: 137
USD 3950.00
(Single User License)
The global Custom DNA Oligos market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 353 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-04-18
Pages: 104
USD 4250.00
(Single User License)
The global Custom DNA Oligos market is projected to grow from US$ 225 million in 2025 to US$ 378 million by 2032, at a CAGR of 7.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 160
The global Custom DNA Oligos market was valued at US$ 225 million in 2025 and is anticipated to reach US$ 378 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 134
The global Custom DNA Oligos market size was US$ 225 million in 2025 and is forecast to reach a readjusted size of US$ 378 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 103
The global market for Custom DNA Oligos was estimated to be worth US$ 225 million in 2025 and is projected to reach US$ 378 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 131
The global market for Custom DNA Oligos was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 353 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-04-18
Pages: 92
The global market for Custom DNA Oligos was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 353 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-04-18
Pages: 137
The global Custom DNA Oligos market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 353 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-04-18
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now